Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 4
2005 4
2006 4
2007 8
2008 17
2009 10
2010 11
2011 18
2012 19
2013 17
2014 22
2015 26
2016 34
2017 27
2018 28
2019 33
2020 31
2021 50
2022 42
2023 57
2024 70
2025 70
2026 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

536 results

Results by year

Filters applied: . Clear all
Page 1
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.
Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Yoshiji H, et al. Among authors: shimizu m. J Gastroenterol. 2021 Jul;56(7):593-619. doi: 10.1007/s00535-021-01788-x. Epub 2021 Jul 7. J Gastroenterol. 2021. PMID: 34231046 Free PMC article. Review.
Virus-Driven Carcinogenesis.
Hatano Y, Ideta T, Hirata A, Hatano K, Tomita H, Okada H, Shimizu M, Tanaka T, Hara A. Hatano Y, et al. Among authors: shimizu m. Cancers (Basel). 2021 May 27;13(11):2625. doi: 10.3390/cancers13112625. Cancers (Basel). 2021. PMID: 34071792 Free PMC article. Review.
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials.
Panaccione R, Feagan BG, Afzali A, Rubin DT, Reinisch W, Panés J, Danese S, Hisamatsu T, Terry NA, Salese L, Van Rampelbergh R, Sahoo A, Vetter ML, Yee J, Han C, Frustaci ME, Wan KYY, Yang Z, Johanns J, Andrews JM, D'Haens GR, Sands BE; GALAXI 2 & 3 Study Group. Panaccione R, et al. Lancet. 2025 Jul 26;406(10501):358-375. doi: 10.1016/S0140-6736(25)00681-6. Epub 2025 Jul 17. Lancet. 2025. PMID: 40684778 Clinical Trial.
Response.
Yoshida K, Iwashita T, Shimizu M. Yoshida K, et al. Among authors: shimizu m. Gastrointest Endosc. 2019 Dec;90(6):996. doi: 10.1016/j.gie.2019.08.027. Gastrointest Endosc. 2019. PMID: 31759424 No abstract available.
Evidence-based clinical practice guidelines for liver cirrhosis 2020.
Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Yoshiji H, et al. Among authors: shimizu m. Hepatol Res. 2021 Jul;51(7):725-749. doi: 10.1111/hepr.13678. Epub 2021 Jul 6. Hepatol Res. 2021. PMID: 34228859
[Liver cirrhosis and sarcopenia].
Shimizu M, Hanai T, Miwa T. Shimizu M, et al. Nihon Shokakibyo Gakkai Zasshi. 2023;120(9):709-716. doi: 10.11405/nisshoshi.120.709. Nihon Shokakibyo Gakkai Zasshi. 2023. PMID: 37690826 Japanese. No abstract available.
Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey.
Miwa T, Tsuruoka M, Ueda H, Abe T, Inada H, Yukawa-Muto Y, Ohara M, Arai T, Tamai Y, Isoda H, Tadokoro T, Hanai T, Ito T, Tamaki N, Sakamaki A, Aoki Y, Tada F, Yoshio S, Takahashi H, Morishita A, Ishikawa T, Inoue J, Suda G, Ogawa C, Atsukawa M, Hiraoka A, Kuroda H, Namisaki T, Honda T, Kawaguchi T, Tanaka Y, Terai S, Ikegami T, Yoshiji H, Iwasa M, Shimizu M. Miwa T, et al. Among authors: shimizu m. J Gastroenterol. 2025 Jul;60(7):866-876. doi: 10.1007/s00535-025-02232-0. Epub 2025 Mar 7. J Gastroenterol. 2025. PMID: 40053108 Free PMC article.
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Matsuoka K, Watanabe M, Ohmori T, Nakajima K, Ishida T, Ishiguro Y, Kanke K, Kobayashi K, Hirai F, Watanabe K, Mizusawa H, Kishida S, Miura Y, Ohta A, Kajioka T, Hibi T; AJM300 Study Group. Matsuoka K, et al. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):648-657. doi: 10.1016/S2468-1253(22)00022-X. Epub 2022 Mar 30. Lancet Gastroenterol Hepatol. 2022. PMID: 35366419 Clinical Trial.
Vonoprazan-associated Diffuse Gastric Mucosal Redness.
Yamazaki K, Kushima R, Shimizu M. Yamazaki K, et al. Among authors: shimizu m. Gastro Hep Adv. 2022 Mar 30;1(3):350-351. doi: 10.1016/j.gastha.2022.01.008. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39131688 Free PMC article. No abstract available.
536 results